Medications

Intestinal drug shown to boost memory and cognition

The development of drugs to treat cognitive problems in patients with mental illness may be a step closer after a team of researchers discovered that an existing drug—used to treat constipation—may be able to boost our ...

Diseases, Conditions, Syndromes

COVID immunity lasts at least eight months, new data reveals

Australian researchers have revealed—for the first time—that people who have been infected with the COVID-19 virus have immune memory to protect against reinfection for at least eight months.

Psychology & Psychiatry

Study finds protein in blood believed to be linked to depression

The process of aging is often related to the onset of neurological symptoms such as cognitive decline, memory loss or mood disorders such as depression. Previous studies have shown that the growth factor GDF11, a protein ...

Diseases, Conditions, Syndromes

Persistent T cell response to omicron after infection and vaccination

The omicron variant can partly evade the antibody response provided by vaccination or infection with previous variants of SARS-CoV-2. However, T cells still recognize omicron, scientists at Karolinska Institutet in Sweden ...

page 2 from 40